FMP
Oct 25, 2024 3:33 PM - Davit Kirakosyan
Image credit: FMP
ResMed (NYSE:RMD) saw its shares rise 8% intra-day today following a robust first-quarter fiscal 2025 report that exceeded Street expectations. The sleep and respiratory care device maker posted adjusted earnings per share of $2.20 for the quarter, above the Street estimate of $2.05. Revenue increased by 11% year-over-year, reaching $1.22 billion and topping projections of $1.19 billion.
ResMed’s operational focus contributed to notable margin gains, with gross margin expanding by 420 basis points to 58.6% and adjusted gross margin rising by 320 basis points to 59.2%. Income from operations also saw a substantial 34% increase compared to the same period last year.
May 14, 2024 11:41 AM - Sanzhi Kobzhan
A stock's target price, also known as its fair value, is an indication of what a share can cost based on the company’s forecasted financial statements. It is important to know a stock's fair value to find undervalued stocks with great growth potential. Let's consider how investment analysts calculat...
May 24, 2024 9:30 AM - Rajnish Katharotiya
Earnings call transcripts are invaluable resources for investors, analysts, and financial enthusiasts. They provide insights into a company's performance, strategy, and future outlook, making them essential for making informed investment decisions. With Financial Modeling Prep, Earnings Call Transcr...
May 27, 2024 3:30 PM - Rajnish Katharotiya
In the ever-evolving world of technology, certain sectors have consistently demonstrated exceptional growth and innovation. The graphics processing units (GPUs) industry is one such sector, offering investors a golden opportunity for potentially high returns. In this blog, we'll delve into why inves...